A SMARTER RECOVERY
NEUROVINE: FAST FACTS

As an "invisible injury," few people realize the long-term problems that can arise from a concussion. Concussion symptoms can plague patients for months or even years, delaying return to work, sports and school. Targeted therapy can speed concussion recovery and prevent devastating secondary impact syndrome. The problem is that this type of therapy is expensive and difficult to access for most patients. 

Neurovine is redefining concussion treatment as the only company to use real-time neurophysiological data to guide concussion recovery. The Neurovine technology platform enables virtual care for this vulnerable patient population. We engage patients in their brain health and provide important metrics to clinicians so they can make informed medical decisions related to recovery and return to play.

A SMARTER RECOVERY
ENORMOUS PROBLEM
Many are affected - few see results

Research has shown the importance of physical and cognitive activity and targeted therapy post-concussion. On the flip side, overexertion or generic therapies may cause recovery regression.

This is a serious problem—there is currently no way for a patient to know how to be cognitively active without overexerting and causing further damage. This contradiction leaves patients and doctors to rely on symptoms and subjective assessments that do not improve health.

Given the current climate created by COVID-19, people feel more isolated than ever in their recovery process. By being unable to access in-person care and by being cut off from support communities, it may feel as if there is nowhere to turn.

A SMARTER RECOVERY
ONE SOLUTION THAT CHANGES EVERYTHING

Neurovine solves these problems by being the only innovator to use real-time neurophysiological data to guide concussion recovery remotely, engaging patients in their brain health. Neurovine provides important metrics to clinicians so they can make informed medical decisions related to recovery and return to normalcy as soon as possible. We built Neurovine from the ground up to offer a new and exciting way to support concussion recovery. Some of our key advantages include:

Proprietary EEG Sensorband

Cloud-based data analytics

the ‘Navigator’ patient mobile application

Clinician web portal

Virtual patient management

Best of all, our work is already complete—we have built, validated and patented the EEG hardware design, the mobile app, the data analytics, and underlying structure of the clinician web portal. Thus, the purpose of this raise is to prepare for sales. We need to increase manufacturing capacity, complete our regulatory work, and refine and validate our clinician web portal.

A SMARTER RECOVERY
WHY WE'LL LEAD

We proudly designed Neurovine to support patients’ mental and physical recovery as they return to school, work, sports, and life in general. Our technology platform has been shown to speed concussion recovery, saving money for patients and payors alike. 

The technology platform will also provide doctors with the ability to make data-driven decisions to help speed concussion recovery. The secure clinician web portal will provide physicians with real-time data insights that have been unavailable to them until now and derive data from their patients’ brain activity. It will be an invaluable decision-support tool, enabling physicians to provide guidance and create treatment programs based on this data.  

A SMARTER RECOVERY
TRACTION & ACCOMPLISHMENTS

Early Success
We have 26 partner clinics currently using our solution with their patients. So far we have logged over 3,000 concussion recovery sessions and user feedback has been overwhelmingly positive. We are on track to add 40 additional clinics in Q1 2022.

Partnerships
In addition to our 26 partner clinics, we have a partnership agreement with ONE9 Investments to work with us in the military/defense industry. We have also had preliminary meetings with Bauer about a manufacturing partnership and with Telus about EMR integration.

Scientifically Recognized
We have had abstracts accepted for presentation at multiple concussion conferences. We have a large scale RCT that will demonstrate the efficacy of the Neurovine solution for insurance payers. 

A SMARTER RECOVERY
MEET THE TEAM

Ashleigh Kennedy, PhD
CHIEF EXECUTIVE OFFICER AND CO-FOUNDER

• Stanford graduate, a thought leader in neurorehabilitation and a decorated public speaker in the area of augmented learning in healthcare
• Has a deep understanding of clinical research and a demonstrated history of medical innovation
• Has led the Neurovine team through a period of acceleration over the past two years despite COVID-19 challenges
• Recipient of the Ottawa 40 under 40 award in 2021

Matthew Kennedy, MSc, MD 
CHIEF MEDICAL OFFICER AND CO-FOUNDER

• Family physician with a special interest in concussion
• Leading the clinical research program at Neurovine, currently running a virtual randomized control trial as well as designing the long-term research program that will position our application as the gold standard in evidence-based concussion recovery
• He is the boots on the ground for the company, treating patients with concussion every day

Patrick Leckey
CHIEF TECHNICAL OFFICER

• Extensive experience in Engineering, with 10 years in Engineering Management
• Is highly technical - growing SaaS applications with 200M+ monthly page views, with stacks including Java, Python, Node.js, PHP (Laravel), React, and Angular

Brent Anderson 
CHIEF OPERATING OFFICER

• Influential leader with a proven track record that drives results and growth; skilled in developing strong and efficient teams, and at streamlining business processes
• Focused on ensuring that Neurovine has the right systems, tools, and processes in place to attract, retain, support, and develop top talent

Heather van Staalduinen
CHIEF MARKETING OFFICER

• Highly motivated marketing professional with a thorough understanding of marketing automation, business development, multi-channel campaign management, project management, and client relations
• Her mission is to build a foundation for company growth while establishing Neurovine as a thought leader in the brain health industry, and to spread the message of optimized, simplified, brain recovery

Kim Butler 
CHIEF FINANCIAL OFFICER

• 30+ years of executive level financial and operational experience gained with large Canadian and multinational organizations
• An accomplished financial leader with strong results orientation coupled with operational and strategic leadership of IT, procurement, sales operation, contract management, legal affairs, and human resources

Lou Pino, PhD 
HEAD OF DATA SCIENCE

• Extensive knowledge of EEG, neuroscience, and machine learning
• Has developed and validated algorithms for wearable products that achieve 4+ star ratings on Amazon and Apple
• Inventor of 11 patents for leading edge, breakthrough innovation

Josh Adams, MBA 
HEAD OF BUSINESS DEVELOPMENT

• Industry leader in commercial market strategy and business development initiatives in the medical sector
• Results-driven B2B leader with an impressive record of improving P&L performance, driving top-line revenue, and executing winning strategies

ADVISORY BOARD

​Tunde Oshinowo

• VC at Sandbox Industries with a deep understanding of insurance reimbursement codes and American billing codes
• NFL alum and an active member of the NFL players association
• Has been working with Neurovine for three years to develop American payer reimbursement strategy

Jacki Jeunth

• Partner and COO at Lumera Ventures
• Deep expertise in financial modeling in healthcare and is supporting Neurovine’s adoption into clinics in Canada and the USA

Ronald Dunn

• As VP of McKesson Technology Solutions Canada for 14 years, Ronald grew top line revenue from $10M in 2001 to $60M in 2014
• Led the business case and spearheaded the subsequent introduction of one of Canada’s first cloud-based application software solutions – RelayHealth

Anthony de Fazekas

• Leading IP attorney with Norton Rose Fulbright
• In his career he has assisted leading IP rich companies in development of their IP strategy and monetization of their IP over the last two decades
• Anthony is supporting Neurovine to prioritize IP development